On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Sunday, April 06, 2014

Simulation Approach to estimate the sample size for Poisson distribution

›
FDA Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Rep...
Sunday, March 30, 2014

Computing Confidence Interval for Poisson Mean

›
For Poisson distribution, there are many different ways for calculating the confidence interval. The paper by Patil and Kulkarni discusses...
5 comments:
Thursday, March 06, 2014

Intra-Subject Coefficient of Variation (CV%) for Sample Size Estimation for Crossover Design

›
To calculate the sample size for a crossover design for bioequivalence study, a key assumption is the intra-subject variation. The intra-su...
4 comments:
Sunday, March 02, 2014

Analysis of 2x2x2 crossover design data: Proc Mixed or Proc GLM

›
In an early article " Cookbook SAS Codes for Bioequivalence Test in 2x2x2 Crossover Design ", I provided the analysis using Proc M...
Monday, February 10, 2014

Sending emails through SAS

›
I am not sure if there is any practical use for sending emails through SAS. But this SAS micro was picked up from RTP SAS User Group Email...
3 comments:
Sunday, February 02, 2014

Conference in Research Triangle Park, NC: TRENDS AND INNOVATIONS IN CLINICAL TRIAL STATISTICS (2014)

›
The research triangle area in North Carolina is one of the area with the concentrated talents in statistics and biostatistics. All three bi...
1 comment:
Sunday, January 26, 2014

FDA Guidance Webinar Series

›
FDA's Guidance Webinar series aims to foster collaboration and transparency in the development of guidance documents through direct ou...
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.